BL-B16D1 Clinical Trials

3 actively recruiting trials

No change since May 2026

Pipeline

Phase 1: 3

Top Sponsors

Sichuan Baili Pharmaceutical Co., Ltd.3

Indications

Solid Tumor3
Cancer3
Head and Neck Squamous Cell Carcinomas1
Breast Cancer1

Other3 trials

A Study of BL-B16D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1

A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Phase 1

A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.